Works matching DE "ALISKIREN"

Results: 219

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 587, doi. 10.1007/s10557-020-07002-z

By:

Zhao, Zhiqiang;
Li, Ruiling;
Wang, Xinghua;
Li, Jian;
Yuan, Meng;
Liu, Enzhao;
Liu, Tong;
Li, Guangping

Publication type:

Article

Protective Effects of Aliskiren on Atrial Ionic Remodeling in a Canine Model of Rapid Atrial Pacing.

Published in:

Cardiovascular Drugs & Therapy, 2014, v. 28, n. 2, p. 137, doi. 10.1007/s10557-014-6509-x

By:

Zhao, Zhiqiang;
Wang, Xinghua;
Li, Jian;
Yang, Wansong;
Cheng, Lijun;
Chen, Yan;
Liu, Tong;
Liu, Enzhao;
Chen, Kangyin;
Li, Guangping

Publication type:

Article

Estimating the Solubility, Solution Thermodynamics, and Molecular Interaction of Aliskiren Hemifumarate in Alkylimidazolium Based Ionic Liquids.

Published in:

Molecules, 2019, v. 24, n. 15, p. 2807, doi. 10.3390/molecules24152807

By:

Anwer, Md. Khalid;
Muqtader, Mohammad;
Iqbal, Muzaffar;
Ali, Raisuddin;
Almutairy, Bjad K.;
Alshetaili, Abdullah;
Alshahrani, Saad M.;
Aldawsari, Mohammed F.;
Alalaiwe, Ahmed;
Shakeel, Faiyaz

Publication type:

Article

Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats.

Published in:

Molecules, 2019, v. 24, n. 15, p. 2710, doi. 10.3390/molecules24152710

By:

Pechanova, Olga;
Barta, Andrej;
Koneracka, Martina;
Zavisova, Vlasta;
Kubovcikova, Martina;
Klimentova, Jana;
Tӧrӧk, Jozef;
Zemancikova, Anna;
Cebova, Martina;
Cicha, Iwona;
Dézsi, László;
Azzawi, May

Publication type:

Article

Norepinephrine Effects on Uropathogenic Strains Virulence.

Published in:

Microorganisms, 2022, v. 10, n. 11, p. 2248, doi. 10.3390/microorganisms10112248

By:

Ignatova, Nadezhda;
Abidullina, Alina;
Streltsova, Olga;
Elagin, Vadim;
Kamensky, Vladislav

Publication type:

Article

Simultaneous determination of aliskiren, amlodipine and hydrochlorothiazide in spiked human plasma and urine by high performance liquid chromatography.

Published in:

Journal of Analytical Chemistry, 2015, v. 70, n. 4, p. 502, doi. 10.1134/S1061934815040176

By:

Aydoǧmuş, Zeynep

Publication type:

Article

Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome.

Published in:

Clinical Kidney Journal, 2020, v. 13, n. 1, p. 39, doi. 10.1093/ckj/sfz146

By:

Plasse, Richard A;
Nee, Robert;
Olson, Stephen W

Publication type:

Article

Aliskiren and the dual complement inhibition concept.

Published in:

Clinical Kidney Journal, 2020, v. 13, n. 1, p. 35, doi. 10.1093/ckj/sfz142

By:

Perez-Gomez, Maria Vanessa;
Ortiz, Alberto

Publication type:

Article

A Validated Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Aliskiren Hemifumarate and Amlodipine Besylate in Pharmaceutical Dosage Form.

Published in:

Chromatography Research International, 2014, p. 1, doi. 10.1155/2014/628319

By:

Runja, Chinnalalaiah;
Ravikumar, P.;
Avanapu, Srinivasa Rao

Publication type:

Article

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

Published in:

Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0282-5

By:

Ramalho, F. N.;
Sanches, S. C.;
Foss, M. C.;
Augusto, M. J.;
Silva, D. M.;
Oliveira, A. M.;
Ramalho, L. N.

Publication type:

Article

Journal Club.

Published in:: Kidney International, 2013, v. 83, n. 5, p. 775, doi. 10.1038/ki.2013.116
Publication type:: Article

Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression.

Published in:

Neurochemical Research, 2016, v. 41, n. 9, p. 2300, doi. 10.1007/s11064-016-1944-7

By:

Miao, Jiangyong;
Wang, Lina;
Zhang, Xiangjian;
Zhu, Chunhua;
Cui, Lili;
Ji, Hui;
Liu, Ying;
Wang, Xiaolu

Publication type:

Article

Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.

Published in:

Expert Review of Cardiovascular Therapy, 2012, v. 10, n. 3, p. 293, doi. 10.1586/ERC.12.7

By:

Judd, Eric;
Jaimes, Edgar A.

Publication type:

Article

Clinical trial terminated after suggested Rasilez® risk.

Published in:

Expert Review of Cardiovascular Therapy, 2012, v. 10, n. 3, p. 280

By:

Rees, Jenaid

Publication type:

Article

Combination therapy with aliskiren and amlodipine in hypertension: treatment rationale and clinical results.

Published in:

Expert Review of Cardiovascular Therapy, 2011, v. 9, n. 4, p. 421, doi. 10.1586/ERC.11.23

By:

Zion, Adrienne S.;
Izzo Jr, Joseph L.

Publication type:

Article

Angiotensin II, tissue factor and the thrombotic paradox of hypertension.

Published in:

Expert Review of Cardiovascular Therapy, 2010, v. 8, n. 12, p. 1723, doi. 10.1586/ERC.10.161

By:

Celi, Alessandro;
Cianchetti, Silvana;
Dell'Omo, Giulia;
Pedrinelli, Roberto

Publication type:

Article

Recent changes in the landscape of combination RAS blockade.

Published in:

Expert Review of Cardiovascular Therapy, 2009, v. 7, n. 11, p. 1373, doi. 10.1586/ERC.09.127

By:

Epstein, Benjamin J.;
Smith, Steven M.;
Choksi, Rushab

Publication type:

Article

Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.

Published in:

Indian Journal of Pharmacology, 2015, v. 47, n. 1, p. 80, doi. 10.4103/0253-7613.150351

By:

Soni, Hitesh M.;
Patel, Praful P.;
Patel, Savan;
Rath, Akshyaya C.;
Acharya, Aviseka;
Trivedi, Harshkant D.;
Jain, Mukul R.

Publication type:

Article

Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing.

Published in:

Molecules, 2022, v. 27, n. 15, p. 4828, doi. 10.3390/molecules27154828

By:

Kunamaneni, Priyanka;
Kovvasu, Surya;
Yeung, Steven;
Wang, Jeffrey;
Shah, Salim;
Betageri, Guru

Publication type:

Article

Hypertension.

Published in:: Nephrology Dialysis Transplantation, 2012, v. 27, n. suppl_2, p. ii26, doi. 10.1093/ndt/gfs188
Publication type:: Article

Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.

Published in:

American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 465, doi. 10.1007/s40256-017-0242-3

By:

Schlienger, Raymond;
Korn, Jonathan;
Wehler, Elizabeth;
Lopez Leon, Sandra;
Yeaw, Jason

Publication type:

Article

Incidence of Ischemic Colitis in Treated, Commercially Insured Hypertensive Adults: A Cohort Study of US Health Claims Data.

Published in:

American Journal of Cardiovascular Drugs, 2015, v. 15, n. 2, p. 135, doi. 10.1007/s40256-014-0101-4

By:

Hines, Dionne;
McGuiness, Catherine;
Schlienger, Raymond;
Makin, Charles

Publication type:

Article

Antihypertensive Drugs, Hypotension, and Ischemic Colitis.

Published in:

American Journal of Cardiovascular Drugs, 2015, v. 15, n. 2, p. 77, doi. 10.1007/s40256-015-0112-9

By:

Blin, Patrick

Publication type:

Article

Epidemiology and Management of Hypertension in the Hispanic Population.

Published in:

American Journal of Cardiovascular Drugs, 2012, v. 12, n. 3, p. 165, doi. 10.2165/11631520-000000000-00000

By:

Guzman, Nicolas J.

Publication type:

Article

Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 327, doi. 10.2165/11591970-000000000-00000

By:

Drummond, W.;
Sirenko, Y. M.;
Ramos, E.;
Baek, I.;
Keefe, D. L.

Publication type:

Article

The Role of Direct Renin Inhibition in Clinical Practice: Focus on Combination Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 303, doi. 10.2165/11594140-000000000-00000

By:

Rashid, Haroon-Ur;
Mende, Christian

Publication type:

Article

Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 1, p. 21, doi. 10.2165/11586570-000000000-00000

By:

Joanne Chang;
Weiyi Yang;
Kahler, Kristijan H.;
Fellers, Thomas;
Orloff, John;
Bensimon, Arielle G.;
Yu, Andrew P.;
Fan, Chun-Po Steve;
Wu, Eric Q.

Publication type:

Article

Aliskiren in the Management of Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 6, p. 349, doi. 10.2165/11584980-000000000-00000

By:

Barrios, Vivencio;
Escobar, Carlos

Publication type:

Article

Protective effect of a direct renin inhibitor in acute murine model of cardiotoxicity and nephrotoxicity.

Published in:

Fundamental & Clinical Pharmacology, 2014, v. 28, n. 5, p. 489, doi. 10.1111/fcp.12054

By:

Rashikh, Azhar;
Pillai, Krishna Kolappa;
Najmi, Abul Kalam

Publication type:

Article

Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00819

By:

Ming-Hsien Chiang;
Chan-Jung Liang;
Chen-Wei Liu;
Bo-Jhih Pan;
Wen-Ping Chen;
Yi-Fan Yang;
I-Ta Lee;
Jaw-Shiun Tsai;
Chiang-Wen Lee;
Yuh-Lien Chen

Publication type:

Article

Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 4, p. 450, doi. 10.1111/1440-1681.12550

By:

Gu, Yue;
Tang, Xin;
Xie, Liping;
Meng, Guoliang;
Ji, Yong

Publication type:

Article

TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.

Published in:

PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202176

By:

Hara, Tomoya;
Nishimura, Satoshi;
Yamamoto, Toshihiro;
Kajimoto, Yumiko;
Kusumoto, Keiji;
Kanagawa, Ray;
Ikeda, Shota;
Nishimoto, Tomoyuki

Publication type:

Article

Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.

Published in:

2018

By:

Chung, Sungjin;
Kim, Soojeong;
Kim, Minyoung;
Koh, Eun Sil;
Shin, Seok Joon;
Park, Cheol Whee;
Chang, Yoon Sik;
Kim, Ho-Shik

Publication type:

Correction Notice

Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Evaluation Study.

Published in:

Journal of Clinical Pharmacology, 2012, v. 52, n. 12, p. 1901, doi. 10.1177/0091270011426432

By:

Villa, Giuseppe;
Le Breton, Stephanie;
Ibram, Ghionul;
Keefe, Deborah L.

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single-Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide.

Published in:

Journal of Clinical Pharmacology, 2012, v. 52, n. 5, p. 645, doi. 10.1177/0091270011405499

By:

Yan, Jing-He;
Jarugula, Venkateswar;
Sabo, Ron;
Papst, Cheraz Cherif;
Zhang, Jack;
Dole, William P.

Publication type:

Article

Laboratory medicine in arterial hypertension.

Published in:

Biochemia Medica, 2023, v. 33, n. 1, p. 1, doi. 10.11613/BM.2023.010501

By:

Aralica, Merica;
Šupak-Smolčić, Vesna;
Honović, Lorena;
Franin, Lucija;
Šonjić, Pavica;
Šimac, Maja;
Horvat, Mihovil;
Poropat, Nina

Publication type:

Article

HPTLC Method for Simultaneous Estimation of Aliskiren, Amlodipine, and Hydrochlorothiazide in Synthetic Mixture Using Quality by Design Approach.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2015, v. 38, n. 16, p. 1546, doi. 10.1080/10826076.2015.1076461

By:

Patel, Tushar R.;
Patel, Tejas B.;
Suhagia, Bhanubhai N.;
Shah, Shailesh A.

Publication type:

Article

Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats.

Published in:

Molecular & Cellular Biochemistry, 2013, v. 373, n. 1/2, p. 189, doi. 10.1007/s11010-012-1489-2

By:

Singh, Yogendra;
Singh, Kulwinder;
Sharma, P.

Publication type:

Article

The use of aliskiren as an antifibrotic drug in experimental models: A systematic review.

Published in:

Drug Development Research, 2020, v. 81, n. 1, p. 114, doi. 10.1002/ddr.21610

By:

Altarejo Marin, Thainá;
Machado Bertassoli, Bruno;
Alves de Siqueira de Carvalho, Alzira;
Feder, David

Publication type:

Article

What Is Pharmacoepidemiology and How Does It Inform Clinical Care?

Published in:

Senior Care Pharmacist, 2024, v. 39, n. 7, p. 240, doi. 10.4140/TCP.n.2024.240

By:

Hillen, Jodie

Publication type:

Article

Hypertension: is it more than just a numbers game?

Published in:

Journal of Physiology, 2013, v. 591, n. 23, p. 5805, doi. 10.1113/jphysiol.2013.266254

By:

Curry, Timothy B.

Publication type:

Article

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure.

Published in:

BMC Pharmacology & Toxicology, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s40360-019-0304-z

By:

Dizaye, Kawa;
Ali, Rojgar H.

Publication type:

Article

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2899, doi. 10.1111/dom.13465

By:

Idzerda, Nienke M. A.;
Persson, Frederik;
Pena, Michelle J.;
Brenner, Barry M.;
Brunel, Patrick;
Chaturvedi, Nish;
McMurray, John J.;
Parving, Hans‐Henrik;
de Zeeuw, Dick;
Heerspink, Hiddo J. L.

Publication type:

Article

Direct renin inhibition improves parasympathetic function in diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2013, v. 15, n. 1, p. 28, doi. 10.1111/j.1463-1326.2012.01669.x

By:

Maser, R. E.;
Lenhard, M. J.;
Kolm, P.;
Edwards, D. G.

Publication type:

Article

Intracellular renin disrupts chemical communication between heart cells. Pathophysiological implications.

Published in:

Frontiers in Endocrinology, 2015, v. 5, p. 1, doi. 10.3389/fendo.2014.00238

By:

De Mello, Walmor C.

Publication type:

Article

Aliskiren Reduces the Adrenal Zona Glomerulosa Apoptosis and Autophagy in Wistar Rats with 2K1C Hypertension.

Published in:

International Journal of Hypertension, 2020, p. 1, doi. 10.1155/2020/7684849

By:

de Matos, Veronica S.;
do Nascimento, Ana L. R.;
Pereira, Priscila G.;
Rabelo, Kíssila;
Andrade, Cherley B. V.;
Moraes, Alan C. N.;
Salata, Camila;
Araújo, Victor H. V. de O.;
Ciambarella, Bianca Torres;
Bonfim Vieira, Aline;
Alves, Luciana Lontro;
da Silva, Jemima F. R.;
de Carvalho, Jorge J.

Publication type:

Article

Effect of Aliskiren on Progression of Coronary Disease in Patients With Prehypertension.

Published in:

JAMA: Journal of the American Medical Association, 2013, v. 310, n. 11, p. 1135, doi. 10.1001/jama.2013.277169

By:

Nicholls, Stephen J.;
Bakris, George L.;
Kastelein, John J. P.;
Menon, Venu;
Williams, Bryan;
Armbrecht, Juergen;
Brunel, Patrick;
Nicolaides, Maria;
Hsu, Amy;
Bo Hu;
Hui Fang;
Rishi Puri;
Kiyoko Uno;
Yu Kataoka;
Bash, Dianna;
Nissen, Steven E.

Publication type:

Article

Renin-Angiotensin System Inhibition and Secondary Cardiovascular Prevention.

Published in:

2013

By:

Tardif, Jean-Claude;
Grégoire, Jean

Publication type:

Editorial

CORRECTIONS.

Published in:: 2013
Publication type:: Correction Notice

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure.

Published in:

JAMA: Journal of the American Medical Association, 2013, v. 309, n. 11, p. 1125, doi. 10.1001/jama.2013.1954

By:

Gheorghiade, Mihai;
Böhm, Michael;
Greene, Stephen J.;
Fonarow, Gregg C.;
Lewis, Eldrin F.;
Zannad, Faiez;
Solomon, Scott D.;
Baschiera, Fabio;
Botha, Jaco;
Hua, Tsushung A.;
Gimpelewicz, Claudio R.;
Jaumont, Xavier;
Lesogor, Anastasia;
Maggioni, Aldo P.

Publication type:

Article